Literature DB >> 17048971

Fatal respiratory depression after multiple intravenous morphine injections.

Jörn Lötsch1, Rafael Dudziak, Rainer Freynhagen, Jürgen Marschner, Gerd Geisslinger.   

Abstract

A 26-year-old female was treated with morphine within the first 2 hours after knee surgery, in an attempt to titrate analgesia. The patient received a total of four intravenous injections of morphine 35 mg in total. Soon after the last injection the patient had adequate pain relief, was in a good clinical state and had adequate blood oxygenation. However, 40 minutes later, the patient had a deep respiratory depression followed by a fatal cardiac arrest. Solving the case in a medico-legal context was possible by applying results of clinical pharmacokinetic research on opioid analgesics, most importantly morphine, to this particular clinical case. This knowledge made it possible to estimate the probable concentrations of morphine at the site of its effect, the brain, during the time of the fatal event, and to show that these concentrations could have produced respiratory depression. We mainly attribute the fatal intoxication of morphine to the lag period needed for the transfer of morphine across the blood-brain barrier. Because of its slow transfer between plasma and the effect site, the CNS effects of morphine are delayed from its plasma concentrations to a clinically relevant degree. Successive injections at short intervals of relatively high amounts of morphine increase the clinical relevance of this delay. The present report demonstrates an important application of clinical pharmacokinetics for explaining clinical observations at a scientific level and transferring theoretical knowledge from clinical pharmacokinetics into daily clinical practice as a basis for rational opioid selection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048971     DOI: 10.2165/00003088-200645110-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  36 in total

1.  Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs.

Authors:  M A Hughes; P S Glass; J R Jacobs
Journal:  Anesthesiology       Date:  1992-03       Impact factor: 7.892

2.  The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers.

Authors:  J Lötsch; C Skarke; H Schmidt; S Grösch; G Geisslinger
Journal:  Anesthesiology       Date:  2001-12       Impact factor: 7.892

3.  Pharmacokinetic parameters relevant to recovery from opioids.

Authors:  E J Youngs; S L Shafer
Journal:  Anesthesiology       Date:  1994-10       Impact factor: 7.892

4.  Postoperative patient-controlled analgesia with alfentanil: analgesic efficacy and minimum effective concentrations.

Authors:  K A Lehmann; N Ribbert; G Horrichs-Haermeyer
Journal:  J Pain Symptom Manage       Date:  1990-08       Impact factor: 3.612

5.  Sex differences in morphine analgesia: an experimental study in healthy volunteers.

Authors:  E Sarton; E Olofsen; R Romberg; J den Hartigh; B Kest; D Nieuwenhuijs; A Burm; L Teppema; A Dahan
Journal:  Anesthesiology       Date:  2000-11       Impact factor: 7.892

6.  Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.

Authors:  C F Minto; T W Schnider; T D Egan; E Youngs; H J Lemmens; P L Gambus; V Billard; J F Hoke; K H Moore; D J Hermann; K T Muir; J W Mandema; S L Shafer
Journal:  Anesthesiology       Date:  1997-01       Impact factor: 7.892

7.  Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain.

Authors:  C E Inturrisi; W A Colburn; R F Kaiko; R W Houde; K M Foley
Journal:  Clin Pharmacol Ther       Date:  1987-04       Impact factor: 6.875

8.  Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers.

Authors:  T D Egan; C F Minto; D J Hermann; J Barr; K T Muir; S L Shafer
Journal:  Anesthesiology       Date:  1996-04       Impact factor: 7.892

9.  EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil.

Authors:  J C Scott; K V Ponganis; D R Stanski
Journal:  Anesthesiology       Date:  1985-03       Impact factor: 7.892

10.  Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B).

Authors:  P S Glass; D Hardman; Y Kamiyama; T J Quill; G Marton; K H Donn; C M Grosse; D Hermann
Journal:  Anesth Analg       Date:  1993-11       Impact factor: 5.108

View more
  19 in total

1.  [Use of controlled release opioids in perioperative pain therapy: a standpoint on a new warning advice in the literature on controlled release opioids].

Authors:  E M Pogatzki-Zahn; P K Zahn; R Sabatowski; M Strumpf; S Wirz; A Wiebalck; H Zirngibl; W Meissner
Journal:  Schmerz       Date:  2009-04       Impact factor: 1.107

Review 2.  Bioequivalence criteria for transdermal fentanyl generics: do these need a relook?

Authors:  Carmen Walter; Lisa Felden; Jörn Lötsch
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 3.  OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain.

Authors:  Natalie J Carter; Gillian M Keating
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

4.  OCT1 genetic variants are associated with postoperative morphine-related adverse effects in children.

Authors:  Rajiv Balyan; Xue Zhang; Vidya Chidambaran; Lisa J Martin; Tomoyuki Mizuno; Tsuyoshi Fukuda; Alexander A Vinks; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2017-05-04       Impact factor: 2.533

5.  Fatal PCA Adverse Events Continue To Happen: Better Patient Monitoring Is Essential to Prevent Harm.

Authors:  Matthew Grissinger
Journal:  P T       Date:  2016-12

6.  Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents.

Authors:  V Chidambaran; J Mavi; H Esslinger; V Pilipenko; L J Martin; K Zhang; S Sadhasivam
Journal:  Pharmacogenomics J       Date:  2014-09-30       Impact factor: 3.550

7.  Fatty acid amide hydrolase-morphine interaction influences ventilatory response to hypercapnia and postoperative opioid outcomes in children.

Authors:  Vidya Chidambaran; Valentina Pilipenko; Kristie Spruance; Raja Venkatasubramanian; Jing Niu; Tsuyoshi Fukuda; Tomoyuki Mizuno; Kejian Zhang; Kenneth Kaufman; Alexander A Vinks; Lisa J Martin; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2016-12-15       Impact factor: 2.533

8.  Multi-Level Regulation of Opioid-Induced Respiratory Depression.

Authors:  Barbara Palkovic; Vitaliy Marchenko; Edward J Zuperku; Eckehard A E Stuth; Astrid G Stucke
Journal:  Physiology (Bethesda)       Date:  2020-11-01

9.  A comparison of the effects of hydromorphone HCl and a novel extended release hydromorphone on arterial blood gas values in conscious healthy dogs.

Authors:  L A Wunsch; B K Schmidt; L A Krugner-Higby; L J Smith
Journal:  Res Vet Sci       Date:  2009-08-18       Impact factor: 2.534

10.  Non-invasive combined surrogates of remifentanil blood concentrations with relevance to analgesia.

Authors:  Jörn Lötsch; Carsten Skarke; Jutta Darimont; Michael Zimmermann; Lutz Bräutigam; Gerd Geisslinger; Alfred Ultsch; Bruno G Oertel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-18       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.